Alternative conformations of HIV-1 V3 loops mimic β hairpins in chemokines, suggesting a mechanism for coreceptor selectivity

Structure

Volumn 11, Issue 2, 2003, Pages 225-236

  Sharon, Michal ^a   Kessler, Naama ^a   Levy, Rina ^a   Zolla Pazner, Susan ^b   Görlach, Matthias ^c   Anglister, Jacob ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

Chemokines; Coreceptor; gp120 V3; HIV 1; Neutralizing antibodies; NMR structure

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCLONAL ANTIBODY; RANTES; STROMAL CELL DERIVED FACTOR 1;

AMINO ACID SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

ANTIBODIES; CHEMOKINES; EPITOPES; HIV ENVELOPE PROTEIN GP120; HIV-1; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; RNA VIRUSES;

EID: 0037317611     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(03)00011-X     Document Type: Article

References (61)

1. Trkola A., Dragic T., Arthos J., Binley J.M., Olson W.C., Allaway G.P., Cheng-Mayer C., Robinson J., Maddon P.J., Moore J.P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 384:1996;184-187.
2. Wu L., Gerard N.P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A.A., Desjardin E., Newman W.et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 384:1996;179-183.
3. Moore J.P., Trkola A., Dragic T. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9:1997;551-562.
4. De Jong J.J., De Ronde A., Keulen W., Tersmette M., Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype. analysis by single amino acid substitution J. Virol. 66:1992;6777-6780.
5. Ratner L., Haseltine W., Patarca R., Livak K.J., Starcich B., Josephs S.F., Doran E.R., Rafalski J.A., Whitehorn E.A., Baumeister K.et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 313:1985;277-284.
6. Rusche J.R., Javaherian K., McDanal C., Petro J., Lynn D.L., Grimaila R., Langlois A., Gallo R.C., Arthur L.O., Fischinger P.J.et al. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc. Natl. Acad. Sci. USA. 85:1988;3198-3202.
7. Kwong P.D., Wyatt R., Majeed S., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Structure. 8:2000;1329-1339.
8. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 393:1998;648-659.
9. Ghiara J.B., Stura E.A., Stanfield R.L., Profy A.T., Wilson I.A. Crystal structure of the principal neutralization site of HIV-1. Science. 264:1994;82-85.
10. Rini J.M., Stanfield R.L., Stura E.A., Salinas P.A., Profy A.T., Wilson I.A. Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. Proc. Natl. Acad. Sci. USA. 90:1993;6325-6329.
11. Stanfield R., Cabezas E., Satterthwait A., Stura E., Profy A., Wilson I. Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs. Structure. 7:1999;131-142.
12. Tugarinov V., Zvi A., Levy R., Anglister J. A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1IIIB V3 peptide. Nat. Struct. Biol. 6:1999;331-335.
13. Myers G., Foley B., Mellows J., Korber B., Jeang K., Wain-Hobson S. Human Retroviruses and AIDS. A Compilation and Analysis of Nucleic Acid and Amino Sequences:1996;Los Alamos National Laboratory, Los Alamos, NM.
14. Nyambi P.N., Gorny M.K., Bastiani L., van der Groen G., Williams C., Zolla-Pazner S. Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions. a new strategy for studying the immunologic relatedness of HIV-1 J. Virol. 72:1998;9384-9391.
15. Cecilia D., KewalRamani V.N., O'Leary J., Volsky B., Nyambi P., Burda S., Xu S., Littman D.R., Zolla-Pazner S. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J. Virol. 72:1998;6988-6996.
16. Conley A.J., Gorny M.K., Kessler J.A., Boots L.J., Ossorio-Castro M., Koenig S., Lineberger D.W., Emini E.A., Williams C., Zolla-Pazner S. Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D. J. Virol. 68:1994;6994-7000.
17. Fouts T.R., Binley J.M., Trkola A., Robinson J.E., Moore J.P. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 71:1997;2779-2785.
18. Gorny M.K., Williams C., Volsky B., Revesz K., Cohen S., Polonis V.R., Honnen W.J., Kayman S.C., Krachmarov C., Pinter A.et al. Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades. J. Virol. 76:2002;9035-9045.
19. Hioe C.E., Xu S., Chigurupati P., Burda S., Williams C., Gorny M.K., Zolla-Pazner S. Neutralization of HIV-1 primary isolates by polyclonal and monoclonal human antibodies. Int. Immunol. 9:1997;1281-1290.
20. Verrier F., Nadas A., Gorny M.K., Zolla-Pazner S. Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6. J. Virol. 75:2001;9177-9186.
21. VanCott T.C., Bethke F.R., Polonis V.R., Gorny M.K., Zolla-Pazner S., Redfield R.R., Birx D.L. Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1. J. Immunol. 153:1994;449-459.
22. Creighton T.E. Proteins, Structures and Molecular Properties. 1995;W.H. Freeman, New York.
23. Thompson J., Pope T., Tung J.S., Chan C., Hollis G., Mark G., Johnson K.S. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus. use of phage display to improve affinity and broaden strain reactivity J. Mol. Biol. 256:1996;77-88.
24. Wuthrich K. NMR of Proteins and Nucleic Acids. 1986;John Wiley, New York.
25. Kleywegt G.J. Recognition of spatial motifs in protein structures. J. Mol. Biol. 285:1999;1887-1897.
26. LaRosa G.J., Davide J.P., Weinhold K., Waterbury J.A., Profy A.T., Lewis J.A., Langlois A.J., Dreesman G.R., Boswell R.N., Shadduck P.et al. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science. 249:1990;932-935.
27. Gao G.F., Tormo J., Gerth U.C., Wyer J.R., McMichael A.J., Stuart D.I., Bell J.I., Jones E.Y., Jakobsen B.K. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature. 387:1997;630-634.
28. Leahy D.J., Axel R., Hendrickson W.A. Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution. Cell. 68:1992;1145-1162.
29. Zhang Z., Lee C.H., Mandiyan V., Borg J.P., Margolis B., Schlessinger J., Kuriyan J. Sequence-specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain. EMBO J. 16:1997;6141-6150.
30. Czaplewski L.G., McKeating J., Craven C.J., Higgins L.D., Appay V., Brown A., Dudgeon T., Howard L.A., Meyers T., Owen J.et al. Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein MIP-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. J. Biol. Chem. 274:1999;16077-16084.
31. Chung C.W., Cooke R.M., Proudfoot A.E., Wells T.N. The three-dimensional solution structure of RANTES. Biochemistry. 34:1995;9307-9314.
32. Wells T.N., Power C.A., Lusti-Narasimhan M., Hoogewerf A.J., Cooke R.M., Chung C.W., Peitsch M.C., Proudfoot A.E. Selectivity and antagonism of chemokine receptors. J. Leukoc. Biol. 59:1996;53-60.
33. Hoh F., Yang Y.S., Guignard L., Padilla A., Stern M.H., Lhoste J.M., van Tilbeurgh H. Crystal structure of p14TCL1, an oncogene product involved in T-cell prolymphocytic leukemia, reveals a novel beta-barrel topology. Structure. 6:1998;147-155.
34. Wilken J., Hoover D., Thompson D.A., Barlow P.N., McSparron H., Picard L., Wlodawer A., Lubkowski J., Kent S.B. Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES. Chem. Biol. 6:1999;43-51.
35. Fernandez E.J., Wilken J., Thompson D.A., Peiper S.C., Lolis E. Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation. Biochemistry. 39:2000;12837-12844.
36. Dealwis C., Fernandez E.J., Thompson D.A., Simon R.J., Siani M.A., Lolis E. Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor. Proc. Natl. Acad. Sci. USA. 95:1998;6941-6946.
37. Ohnishi Y., Senda T., Nandhagopal N., Sugimoto K., Shioda T., Nagal Y., Mitsui Y. Crystal structure of recombinant native SDF-1alpha with additional mutagenesis studies. an attempt at a more comprehensive interpretation of accumulated structure-activity relationship data J. Interferon Cytokine Res. 20:2000;691-700.
38. Wang W.K., Dudek T., Essex M., Lee T.H. Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization. therapeutic and prophylactic implications Proc. Natl. Acad. Sci. USA. 96:1999;4558-4562.
39. Tugarinov V., Zvi A., Levy R., Hayek Y., Matsushita S., Anglister J. NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding. Structure. 8:2000;385-395.
40. Chandrasekhar K., Profy A.T., Dyson H.J. Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120. Biochemistry. 30:1991;9187-9194.
41. Hansen J.E., Lund O., Nielsen J.O., Brunak S., Hansen J.E. Prediction of the secondary structure of HIV-1 gp120. Proteins. 25:1996;1-11.
42. Nardese V., Longhi R., Polo S., Sironi F., Arcelloni C., Paroni R., DeSantis C., Sarmientos P., Rizzi M., Bolognesi M.et al. Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES. Nat. Struct. Biol. 8:2001;611-615.
43. Kissler S., Susal C., Opelz G. Anti-MIP-1alpha and anti-RANTES antibodies. new allies of HIV-1? Clin. Immunol. Immunopathol. 84:1997;338-341.
44. Basmaciogullari S., Babcock G.J., Van Ryk D., Wojtowicz W., Sodroski J. Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding. J. Virol. 76:2002;10791-10800.
45. Sakaida H., Hori T., Yonezawa A., Sato A., Isaka Y., Yoshie O., Hattori T., Uchiyama T. T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection. J. Virol. 72:1998;9763-9770.
46. Verrier F., Borman A.M., Brand D., Girard M. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage. AIDS Res. Hum. Retroviruses. 15:1999;731-743.
47. Gorny M.K., Xu J.Y., Karwowska S., Buchbinder A., Zolla-Pazner S. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. J. Immunol. 150:1993;635-643.
48. Kuloglu E.S., McCaslin D.R., Markley J.L., Volkman B.F. Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions. J. Biol. Chem. 277:2002;17863-17870.
49. Sharon M., Gorlach M., Levy R., Hayek Y., Anglister J. Expression, purification, and isotope labeling of a gp120 V3 peptide and production of a Fab from a HIV-1 neutralizing antibody for NMR studies. Protein Expr. Purif. 24:2002;374-383.
50. Kessler, N., Zvi, A., Ji, M., Sharon, M., Rosen, O., Levy, R., Gorny, M., Zolla-Pazner, S., and Anglister, J. Expression purification and isotope labeling of the Fv fragmnet of the human HIV-1 neutralizing antibody 447-52D for NMR studies. Protein Expr. Purif., in press.
51. Kay L.E., Nicholson L.K., Delaglio F., Bax A., Torchia D.A. Pulse sequences for removal of the effects of cross-correlation between dipolar and chemical-shift anisotropy relaxation mechanism on the measurement of heteronuclear T1 and T2 values in proteins. J. Magn. Reson. 97:1992;359-375.
52. Sattler M., Schleucher J., Griesinger C. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog. Nucl. Magn. Res. Spectrosc. 34:1999;93-158.
53. Pervushin K. Impact of transverse relaxation optimized spectroscopy (TROSY) on NMR as a technique in structural biology. Q. Rev. Biophys. 33:2000;161-197.
54. Vuister G.W., Bax A. Quantitative J correlation - a new approach for measuring homonuclear 3-bond J(H(N)H(Alpha)) coupling-constants in N-15-enriched proteins. J. Am. Chem. Soc. 115:1993;7772-7777.
55. Roberts G.C.K. NMR of Macromolecules. 1993;Oxford University Press, New York.
56. Cornilescu G., Delaglio F., Bax A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR. 13:1999;289-302.
57. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., Bax A. NMRPipe. a multidimensional spectral processing system based on UNIX pipes J. Biomol. NMR. 6:1995;277-293.
58. Neidig K.-P., Geyer M., Gorler A., Antz C., Saffrich R., Beneicke W., Kalbitzer H. AURELIA, a program for computer-aided analysis of multidimensional NMR spectra. J. Biomol. NMR. 6:1995;255-270.
59. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S.et al. Crystallography and NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921.
60. Koradi, R., Billeter, M., and Wuthrich, K. (1996). MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14, 51-55, 29-32.
61. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., Thornton J.M. Aqua and procheck-nmr. programs for checking the quality of protein structures solved by nmr J. Biomol. NMR. 8:1996;477-486.